Skip to content

XLV

ETF

Health Care Select Sector SPDR Fund

State Street · equity

Current · holdings 2026-11-03
1

Fund snapshot

The basics: what it costs, how big it is, and how it's moved lately.

Short-term · Daily
Gross expense ratio
Net assets
$49.10B
Yield
1.38%
Positions
63
Return · 1 yr
+32.4%
Return · 3 yr
+16.9%
+5.5%this week

+6.2% vs the broad market

2

What you actually own

The biggest positions, and where the money is concentrated.

Intermediate · Weekly

Asset mix

63 positions across 2 asset types
Common Stock99.8%
Other0.2%

Top holdings

Top 10 = 61% of the fund
  • 1LLYELI LILLY + CO16.89%
  • 2JNJJOHNSON + JOHNSON9.61%
  • 3ABBVABBVIE INC7.57%
  • 4UNHUNITEDHEALTH GROUP INC5.44%
  • 5MRKMERCK + CO. INC.5.35%
  • 6TMOTHERMO FISHER SCIENTIFIC INC3.87%
  • 7AMGNAMGEN INC3.73%
  • 8GILDGILEAD SCIENCES INC3.11%
  • 9ABTABBOTT LABORATORIES2.84%
  • 10PFEPFIZER INC2.56%
Show all 63 positions
  • 11ISRGINTUITIVE SURGICAL INC2.33%
  • 12DHRDANAHER CORP2.16%
  • 13VRTXVERTEX PHARMACEUTICALS INC2.01%
  • 14BMYBRISTOL MYERS SQUIBB CO1.89%
  • 15MDTMEDTRONIC PLC1.81%
  • 16CVSCVS HEALTH CORP1.75%
  • 17MCKMCKESSON CORP1.75%
  • 18SYKSTRYKER CORP1.62%
  • 19REGNREGENERON PHARMACEUTICALS1.43%
  • 20ELVELEVANCE HEALTH INC1.34%
  • 21MRNAMODERNA INC1.27%
  • 22CITHE CIGNA GROUP1.17%
  • 23HCAHCA HEALTHCARE INC1.02%
  • 24CORCENCORA INC0.97%
  • 25BSXBOSTON SCIENTIFIC CORP0.94%
  • 26CAHCARDINAL HEALTH INC0.88%
  • 27EWEDWARDS LIFESCIENCES CORP0.82%
  • 28BDXBECTON DICKINSON AND CO0.81%
  • 29IDXXIDEXX LABORATORIES INC0.79%
  • 30HUMHUMANA INC0.75%
  • 31AAGILENT TECHNOLOGIES INC0.74%
  • 32VEEVVEEVA SYSTEMS INC CLASS A0.68%
  • 33WATWATERS CORP0.68%
  • 34IQVIQVIA HOLDINGS INC0.65%
  • 35BIIBBIOGEN INC0.55%
  • 36GEHCGE HEALTHCARE TECHNOLOGY0.55%
  • 37ILMNILLUMINA INC0.54%
  • 38ZTSZOETIS INC0.51%
  • 39MTDMETTLER TOLEDO INTERNATIONAL0.51%
  • 40CNCCENTENE CORP0.50%
  • 41RMDRESMED INC0.49%
  • 42DXCMDEXCOM INC0.47%
  • 43LHLABCORP HOLDINGS INC0.43%
  • 44WSTWEST PHARMACEUTICAL SERVICES0.43%
  • 45DGXQUEST DIAGNOSTICS INC0.41%
  • 46STESTERIS PLC0.34%
  • 47VTRSVIATRIS INC0.33%
  • 48INCYINCYTE CORP0.30%
  • 49ZBHZIMMER BIOMET HOLDINGS INC0.28%
  • 50RVTYREVVITY INC0.27%
  • 51CRLCHARLES RIVER LABORATORIES0.25%
  • 52SSI US GOV MONEY MARKET CLASS0.21%
  • 53BAXBAXTER INTERNATIONAL INC0.20%
  • 54SOLVSOLVENTUM CORP0.18%
  • 55COOCOOPER COS INC/THE0.18%
  • 56TECHBIO TECHNE CORP0.17%
  • 57PODDINSULET CORP0.16%
  • 58ALGNALIGN TECHNOLOGY INC0.15%
  • 59UHSUNIVERSAL HEALTH SERVICES B0.14%
  • 60HSICHENRY SCHEIN INC0.12%
  • 61DVADAVITA INC0.09%
  • 62IXCZ6XAV HEALTH CARE DEC260.02%
  • 632602335DCONTRA HOLOGIC INCORPO0.00%

Sector mix

Health Care99.8%
More breakdowns

Company size

Mega55.6%
Large44.1%
Mid0.1%

Country

US99.8%

Industry

Pharmaceuticals37.1%
Biotechnology20.0%
Health Care Equipment14.7%
Life Sciences Tools & Services9.6%
Managed Health Care8.0%
Health Care Services3.9%
3

What could move this fund

The forces this fund tends to react to: broad economic shifts, leading sectors, and its biggest single names.

Long-term · 1–3 yr

Economic forces

  • Labor markettends to falls with it
  • Interest ratestends to falls with it
  • Economic growthtends to rises with it

Leading sectors

  • Health Care100%

Biggest names

4

Concentration & overlap

How spread out the fund is, and how much it shares with other funds.

Intermediate · Weekly

Concentration

concentrated

The top 10 holdings make up 61% of the fund, and the single largest is 16.9%.

Show details

Concentration score (HHI): 594. Higher means more of the fund sits in fewer holdings.

Overlap with another fund

Pick a fund to see how many of the same holdings they share.

Overlap with the broad market

  • ACWI6% shared · 49 names
  • QQQ3% shared · 8 names
  • ROBO2% shared · 2 names
  • SPY10% shared · 60 names
  • VFIAX9% shared · 59 names
  • FXAIX9% shared · 58 names
  • FBALX5% shared · 19 names
  • FBGRX5% shared · 10 names
  • FCNTX7% shared · 24 names
  • VOO9% shared · 59 names
  • VTI8% shared · 60 names
  • VTSAX8% shared · 60 names
  • XOVR1% shared · 2 names
  • FCTDX4% shared · 59 names
  • FXNAX0% shared · 33 names
  • FIWGX0% shared · 14 names
  • FUSIX0% shared · 2 names
  • IVV9% shared · 59 names
  • DIA13% shared · 4 names
5

Insight summary

A clear read on this fund, written from the data above.

Long-term · 1–3 yr

XLV is a concentrated fund holding 63 US health care stocks, with 61% of its value in just 10 companies. It is heavily weighted toward mega-cap pharma and biotech firms.

This fund tracks the S&P 500 Health Care Select Sector Index. It holds 99.8% of its assets in common stocks of US companies. The portfolio is concentrated, meaning a few large companies drive most of the results. The top three industries are Pharmaceuticals (37.1%), Biotechnology (20.0%), and Health Care Equipment (14.7%). The holdings data is current as of November 3, 2026.

What to watch: The fund is sensitive to labor market conditions and interest rate changes. Its performance is closely tied to the earnings of its largest holdings, such as Eli Lilly and AbbVie.

6

Data freshness

How current the numbers on this page are.

Short-term · Daily

Holdings as of 2026-11-03 (updated daily).

Holdings as of 2026-11-03 · Prices as of 2026-11-04 · 2 day(s) since last disclosure

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.